<DOC>
	<DOCNO>NCT01007019</DOCNO>
	<brief_summary>First human study</brief_summary>
	<brief_title>Safety/Tolerability Pharmacokinetics/Pharmacodynamics YH4808 After Oral Administration Healthy Male Subjects</brief_title>
	<detailed_description>Study evaluate safety tolerability , pharmacokinetics/pharmacodynamics ( PK/PD ) parameter escalate , single dose/repeat dos YH4808 healthy subject .</detailed_description>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Healthy male volunteer age 20 45 year old Subjects determine appropriate screen Weight : 50kg , within ±20 % ideal body weight Subjects sign write consent receive thorough explanation trial purpose , content , characteristic investigational drug Clinically significant disorder liver , kidney , cardiovascular , respiratory system , endocrine system CNS physical examination clinical laboratory test medical history malignant tumor psychological disease Medical history gastrointestinal disease acid restrain surgery , gastric/esophagus surgery ( exclude appendectomy , hernia surgery ) A history hypersensitivity drug clinically significant allergic disease Clinically significant abnormal value blood chemistry ( ≥ 1.5 fold normal upper limit level SGOT , SGPT ) Subjects unable applicable pH meter catheter Subjects history drug abuse positive result urine drug screen Subjects take usual dose prescription drug within 14 day treatment use usual dose OTC drug within 7 day treatment ( cf , able enrol study accord investigatory consideration ) Subjects participate another clinical trial within 3 month enrol study Subjects donate whole blood within 2 month component blood within 1 month donate within 1 month treatment Subjects drank Over 21 units/week alcohol subject n't able stop drinking alcohol hospitalization Subjects stop smoke within 3 month treatment Subjects beverage contain grapefruit within 24hrs hospitalization beverage contain grapefruit hospitalization Subjects beverage contain caffeine hospitalization H.pylori positive result Urease breath test ( Only repeat dos ) Subjects clinically significant observation consider unsuitable base medical judgment investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Safety , tolerability PK/PD</keyword>
</DOC>